The local lymph node assay: past, present and future

被引:150
作者
Kimber, I
Dearman, RJ
Basketter, DA
Ryan, CA
Gerberick, GF
机构
[1] Syngenta Cent Toxicol Lab, Macclesfield SK10 4TJ, Cheshire, England
[2] Unilever Res Labs Colworth, Colworth House, SEAC, Toxicol Unit, Sharnbrook MK44 1LQ, Beds, England
[3] Procter & Gamble Co, Miami Valley Labs, Cincinnati, OH USA
关键词
allergic contact dermatitis; hazard identification; local lymph node assay; lymphocyte proliferation; potency assessment; risk assessment; skin sensitization;
D O I
10.1034/j.1600-0536.2002.470601.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The local lymph node assay (LLNA) was developed originally as a method for the identification of chemicals that have the potential to cause skin sensitization and allergic contact dermatitis. The assay is based on an understanding that the acquisition of contact sensitization is associated with, and dependent upon, the stimulation by chemical allergens of lymphocyte proliferative responses in skin-draining lymph nodes. Those chemicals that provoke a defined level of lymph node cell (LNC) proliferation (a 3-fold or greater increase compared with concurrent vehicle controls) are classified as skin sensitizers. Following its original inception and development, the LLNA was the subject of both national and international interlaboratory collaborative trials, and of very detailed comparisons with other test methods and with human skin sensitization data. The assay has now been validated fully as a stand-alone test for the purposes of hazard identification. In recent years, there has been a growing interest also in the use of the LLNA to assess the potency of contact allergens and in risk assessment. There is reason to believe that the extent of skin sensitization achieved is associated with the vigour of LNC proliferation induced in draining nodes. Given this relationship, the relative potency of skin sensitizing chemicals is measured in the LLNA by derivation of an EC3 value, this being the concentration of chemical required to provoke a 3-fold increase in the proliferation of LNC compared with controls. Experience to date indicates that relative potency as determined using this approach correlates closely with what is known of the activity of skin sensitizing chemicals in humans. In this article, we review the development, evaluation and validation of the LLNA for the purposes of hazard identification, and the more recent application of the method for evaluation of potency in the context of risk assessment. In addition, we consider what new applications and modifications are currently being investigated.
引用
收藏
页码:315 / 328
页数:14
相关论文
共 134 条
[1]  
Andersen KE, 1995, ACTA DERM-VENEREOL, V75, P463
[2]  
[Anonymous], TOXICOLOGY CONTACT H
[3]  
[Anonymous], TOXICOLOGY CONTACT D
[4]  
[Anonymous], ALT LAB ANIMALS
[5]   Local lymph node activation in rats after dermal application of the sensitizers 2,4-dinitrochlorobenzene and trimellitic anhydride [J].
Arts, JHE ;
Droge, SCM ;
Bloksma, N ;
Kuper, CF .
FOOD AND CHEMICAL TOXICOLOGY, 1996, 34 (01) :55-62
[6]   MECHANISTIC RELATIONSHIP AMONG MUTAGENICITY, SKIN SENSITIZATION, AND SKIN CARCINOGENICITY [J].
ASHBY, J ;
HILTON, J ;
DEARMAN, RJ ;
CALLANDER, RD ;
KIMBER, I .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 101 (01) :62-67
[7]  
Basketter D A, 1999, Am J Contact Dermat, V10, P207
[8]  
Basketter D. A., 1998, International Journal of Cosmetic Science, V20, P141, DOI 10.1046/j.1467-2494.1998.171746.x
[9]  
Basketter D.A., 1991, TOXICOL MECH METHOD, V1, P30, DOI DOI 10.3109/15376519109036523
[10]   Use of the local lymph node assay for the estimation of relative contact allergenic potency [J].
Basketter, DA ;
Blaikie, L ;
Dearman, RJ ;
Kimber, I ;
Ryan, CA ;
Gerberick, GF ;
Harvey, P ;
Evans, P ;
White, IR ;
Rycroft, RJG .
CONTACT DERMATITIS, 2000, 42 (06) :344-348